US 12,433,901 B2
Compounds and methods for prevention and treatment of coronavirus infections
Jir-Mehng Lo, Hsinchu (TW); Cheng Huang, Taichung (TW); Yeh B Wu, Hsinchu (TW); Hui-Ju Liang, Taipei (TW); Pei-Hsin Lin, Hsinchu (TW); Hao Chiang, Taipei (TW); and Wei-Chung Chiou, Taipei (TW)
Assigned to ARJIL BIOTECH HOLDING COMPANY LIMITED, Hsinchu (TW)
Filed by ARJIL BIOTECH HOLDING COMPANY LIMITED, Hsinchu (TW)
Filed on Apr. 30, 2021, as Appl. No. 17/245,828.
Claims priority of provisional application 63/018,690, filed on May 1, 2020.
Prior Publication US 2021/0338690 A1, Nov. 4, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/575 (2006.01); A61K 31/365 (2006.01); A61K 31/4162 (2006.01); A61K 45/06 (2006.01); A61P 31/14 (2006.01)
CPC A61K 31/575 (2013.01) [A61K 31/365 (2013.01); A61K 31/4162 (2013.01); A61K 45/06 (2013.01); A61P 31/14 (2018.01)] 1 Claim
 
1. A method for inhibiting SARS-COV-2 infection comprising
administering to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of a compound or pharmaceutically acceptable salt thereof, or its mixture, in which the compound is selected from the group consisting of:

OG Complex Work Unit Chemistry